Now that they have cleared the human genome and both the Rat central nervous system and now the respiratory system the drug has been heavily derisked leading into the final 3 test results before first human dosing
- Forums
- ASX - By Stock
- NYR
- Ann: Brain Injury Program GLP Studies Further Update No 3
NYR
nyrada inc.
Add to My Watchlist
4.26%
!
24.5¢

Ann: Brain Injury Program GLP Studies Further Update No 3, page-2
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
24.5¢ |
Change
0.010(4.26%) |
Mkt cap ! $51.67M |
Open | High | Low | Value | Volume |
23.5¢ | 26.5¢ | 23.5¢ | $245.5K | 1.003M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20047 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.5¢ | 27531 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20047 | 0.235 |
1 | 250000 | 0.230 |
1 | 50000 | 0.225 |
5 | 88773 | 0.220 |
2 | 120005 | 0.215 |
Price($) | Vol. | No. |
---|---|---|
0.245 | 27531 | 2 |
0.255 | 33711 | 2 |
0.260 | 4500 | 1 |
0.265 | 49139 | 1 |
0.270 | 40000 | 1 |
Last trade - 12.55pm 18/06/2025 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
SPONSORED BY The Market Online